Multiple myeloma (MM) is a cancer that begins in the plasma cells (PC) and progresses to
the bone marrow. It is a recurring disease, as no definitive solution can be found despite the …

Multiple Myeloma: Examining the Condition's Page 1 Review Article E-ISSN 2250-0944 || ISSN
2250-1150 1031838/jprt/050202 Multiple Myeloma: Examining the Condition's Symptoms, Causes …

Multiple myeloma represents a malignant proliferation of plasma cells derived from a single
clone. The tumor, its products and the host response to it result in a number of organ …

Multiple myeloma (MM) is a malignant hematological disease. The disease is characterized
by the clonal proliferation of malignant plasma cells in the bone marrow. MM accounts for …

This review summarizes the therapeutic strategies and the drugs actually in development for
the management of myeloma patients. Multiple myeloma is caused by the expansion of …

Multiple myeloma is a disease of malignant plasma cells in the bone marrow. Interaction of
malignant plasma cells with the bone marrow microenvironment plays a key role in the …

This literature review presents the most recent developments in the management of multiple
myeloma, which is characterized by the presence of abnormal plasma cells (myeloma cells) …

Progress in our understanding of multiple myeloma and its treatment has resulted in a more
tailored approach to patient management, with different therapeutics regimens for different …

Despite all the new advances, treatment of multiple myeloma remains very challenging.
Table 6 summarizes the outcomes of some of the commonly used treatments from different …

Multiple myeloma (MM) is a plasma cell neoplasm, characterized by periods of remission
and relapses. The emergence of novel therapies, with multiple mechanisms of action and …